Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researchers identify mechanism that explains lower-quality immune response in COVID-19 patients

The release of massive amounts of proteins called cytokines can lead to some of the most severe symptoms of COVID-19.

20 Aug 2020

Could the high rate of mutations bring about SARS-CoV-2's extinction in India?

A new study published on the preprint server bioRxiv in August 2020 shows the importance of uncovering the dynamics of the virus with particular attention to geographic variation.

19 Aug 2020

Fresh and frozen food can harbor SARS-CoV-2 for at least 21 days

A recent study published on the preprint server bioRxiv in August 2020 suggests that foodborne contamination may underlie these outbreaks and that this route of transmission should not be overlooked to contain the pandemic.

19 Aug 2020

Cytokine storms may prevent the development of long-term immunity to SARS-CoV-2

Shiv Pillai, MD, PhD, investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that that high levels of some cytokines seen in COVID-19 patients, as part of a cytokine storm, may prevent the development of long-term immunity to SARS-CoV-2, the virus that causes COVID-19.

19 Aug 2020

Study reveals important trends in early COVID-19 patients in Massachusetts

Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.

19 Aug 2020

Adaptions to aging may be impacted by genetic background

How we adapt to aging late in life may be genetically influenced, according to a study led by a psychologist at the University of California, Riverside.

19 Aug 2020

Genomics study shows multiple and diverse SARS-CoV-2 introductions in the US capital region

A recent study led by the researchers from Johns Hopkins University reveals multiple and diverse introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States National Capital Region during the initial phase of coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the medRxiv* preprint server.

19 Aug 2020

Researchers use heparin to block co-receptor for SARS-CoV-2 infection

Researchers at the University of Amsterdam have conducted a study showing that heparan sulfate proteoglycans are important co-receptors that severe acute respiratory syndrome 2 (SARS-CoV-2) requires to infect host cells.

19 Aug 2020

CUNY School of Medicine and TechnoVax announce COVID-19 vaccine breakthrough

The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19.

19 Aug 2020

Human microbiome trims mucosal glycans, influencing SARS-CoV-2 infection

An international team of researchers has conducted a study showing that differences in the human microbiome may influence the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.

19 Aug 2020

New 3D digital segmented models for COVID-19 diagnosis

An LSU Health New Orleans radiologist and evolutionary anatomist have teamed up to show the same techniques used for research on reptile and bird lungs can be used to help confirm the diagnosis of COVID-19 in patients.

19 Aug 2020

COVID-19 patients with hypoxia respond positively to a treatment, study shows

Covid-19 patients with hypoxia respond positively to icatibant treatment, Radboud university medical center researchers wrote in JAMA Network Open.

19 Aug 2020

Democratic convention, night 2: Defending the ACA and attacking Trump on pandemic

The second night of the 2020 Democratic National Convention featured a 17-person keynote speech, past presidents, a roll call vote that doubled as a virtual tour of the United States and an emphasis on health care and national security issues.

19 Aug 2020

Mathematical modeling helps researchers track and tackle COVID-19 pandemic

The Editor-in-Chief Vitaly Volpert of the Institut Camille Jordan, University ofLyon, France, reviews how the public's new favourite scientific discipline, mathematical modelling, is being used to track and tackle the COVID-19 pandemic.

19 Aug 2020

Study: Frailty can better predict COVID-19 survival than patient's age

New research from Karolinska Institutet shows that the degree of frailty, a measure of a person's functional level before contracting the disease, can better predict COVID-19 survival than the patient's age

19 Aug 2020

Pioneering program empowers stroke survivors during COVID-19 lockdown

A pioneering program to empower people living with complex long-term conditions such as a stroke or multiple trauma manage their own rehabilitation has been kept on the road during the coronavirus pandemic – thanks to an expert from Kingston University and St George’s, University of London taking the service to online.

19 Aug 2020

Single-dose adenovirus-vectored vaccine protects mice against SARS-CoV-2

The researchers selected the human adenovirus type 5 on which to base their vaccine because this replication-defective vector had already been used in their Ebola vaccine, with an excellent safety and immunogenicity profile in a phase 1 trial. The current study aimed to produce a vaccine that could offer mucosal vaccination and enhanced protection against this respiratory virus.

19 Aug 2020